Can Uric Acid Distinguish Lipedema From Overweight? - Scorecard - MDSpire

Can Uric Acid Distinguish Lipedema From Overweight?

Metabolomics analysis identified higher uric acid levels in patients with lipedema and lymphedema, although associations weakened following adjustment for renal insufficiency.

  • By

  • Andrea Surnit

  • May 29, 2026

  • 3 min

Share

Clinical Scorecard: Can Uric Acid Distinguish Lipedema From Overweight?

At a Glance

CategoryDetail
Condition
Key MechanismsUric acid levels and uric acid-to-cystatin c clearance ratio in the context of lipedema.
Target Population
Care Setting

Key Highlights

  • Remove the statement about statistical significance diminishing after adjusting for age, BMI, and renal function.

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • t
    • h
    • e
    • s
    • u
    • g
    • g
    • e
    • s
    • t
    • i
    • o
    • n
    • t
    • o
    • c
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • u
    • r
    • i
    • c
    • a
    • c
    • i
    • d
    • l
    • e
    • v
    • e
    • l
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Remove unsupported claims about uric acid-lowering agents.

        Clinical Best Practices

        • Ensure all practices are directly supported by the source.

        Related Resources & Content

        Original Source(s)

        Can Uric Acid Distinguish Lipedema From Overweight?

        • by Andrea Surnit

        • May 29, 2026

        Related Content

        Pasteurized Akkermansia muciniphila alleviates high-fat diet-induced bone loss via Nr4a1-dependent Treg differentiation

        T1DM Pregnancy Linked to Gum Inflammation

        Pregnant patients with type 1 diabetes had higher bleeding-on-probing and plaque levels than healthy controls in a small pilot study, though most other periodontal measures did not differ significantly between groups.

        Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions